Osteoprotegerin Ligand Regulates Osteoclast Adherence to the Bone Surface in Mouse Calvaria

This publication has 30 references indexed in Scilit:

• A Chimeric Form of Osteoprotegerin Inhibits Hypercalcemia and Bone Resorption Induced by IL-1β, TNF-α, PTH, PTHrP, and 1,25(OH)2D3
  Journal of Bone and Mineral Research, 1999
• Osteoclast Differentiation Factor Mediates an Essential Signal for Bone Resorption Induced by 1α,25-Dihydroxyvitamin D3, Prostaglandin E2, or Parathyroid Hormone in the Microenvironment of Bone
  Biochemical and Biophysical Research Communications, 1998
• Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
  Cell, 1998
• Osteoclast integrin ? V ? 3 is present in the clear zone and contributes to cellular polarization
  Cell and tissue research, 1996
• Derivation of osteoclasts from hematopoietic colony-forming cells in culture
  Journal of Bone and Mineral Research, 1992
• ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1
  Experimental Cell Research, 1991
• Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria
  Journal of Bone and Mineral Research, 1989
• 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
  Journal of Clinical Investigation, 1987
• Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
  The Journal of Experimental Medicine, 1986
• Osteoclasts derived from haematopoietic stem cells
  Nature, 1980